Attached files

file filename
10-Q/A - AMENDMENT NO. 1 TO QUARTERLY REPORT - BIOFORCE NANOSCIENCES HOLDINGS, INC.bfnh10q0621.htm
EX-32.1 - CERTIFICATION - BIOFORCE NANOSCIENCES HOLDINGS, INC.ex321.htm
EX-31.2 - CERTIFICATION - BIOFORCE NANOSCIENCES HOLDINGS, INC.ex312.htm
EX-31.1 - CERTIFICATION - BIOFORCE NANOSCIENCES HOLDINGS, INC.ex311.htm
EX-10.1 - CONSULTING AGREEMENT - BIOFORCE NANOSCIENCES HOLDINGS, INC.ex101.htm

Exhibit 32.2

AMENDED CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of Bioforce Nanosciences Holdings, Inc., a Nevada corporation (the "Company"), do hereby certify, to the best of their knowledge, that:

 

1.     The Amended Quarterly Report on Form 10-Q/A for the period ending June 30, 2021 (the "Report") of the Company complies in all material respects with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.     The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  

 

Dated:July 30, 2021

/s/Richard Kaiser

Richard Kaiser

Acting Chief Financial Officer